Trial Profile
A Randomized, Multi-Center, Double Blinded, Allopurinol-Controlled, Placebo-Controlled Parallel Group, 5-Arm, Dose-Response,Bridging Study to Assess the Efficacy and Safety of Febuxostat in Subject With Gout
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary) ; Allopurinol; Colchicine
- Indications Gout
- Focus Adverse reactions; Therapeutic Use
- Sponsors SK Chemicals
- 09 Sep 2014 New trial record